Literature DB >> 15104149

[Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger].

A Garba1, G Campagne, J M Tassie, A Barkire, C Vera, B Sellin, J P Chippaux.   

Abstract

Although it is established that the treatment by praziquantel reduces the urinary lesions due to Schistosoma haematobium, the frequency of mass treatment necessary to maintain a low morbidity level remains poorly known. The objective of this work was to study the impact over three years of a single praziquantel mass treatment on schistosomiasis morbidity in two different systems of disease transmission in Niger. The study was performed in 2 villages hyperendemic for schistosomiasis in the South-West of Niger presenting respectively 2 different systems of schistosomiasis transmission: Koutoukalé-Zéno (K Zéno), located close to an irrigated area of the Niger River Valley where the transmission is permanent, and Téguey located along a temporary pond where the transmission is seasonal. After the initial evaluation (1994), we carried out a survey 3 years later (1997) except in K. Zéno where an intermediate evaluation was performed 10 months after the initial survey (1995). Approximately 300 randomised people have been examined as follows: macroscopic examination of urine and reagent sticks for macro- and micro-haematuria, filtration and microscopic examination of urine for Schistosoma eggs, and ultrasound scan of the urinary tract for morbidity. The therapeutic coverage has reached 69.9% in K. Zéno and 78.2% in Téguey. The prevalence of infestation decreased from 74.1% to 56.4 % in K. Zéno (p < 0.001) and from 65.3% to 30.4% in Téguey (p < 0.001) at the end of the 3 years. The prevalence of heavy infestation (eggs > or = 50) went in the same time from 9.9% to 12.8% (p = 0.3) in K. Zéno and from 9.1% to 3.3% in Téguey (p = 0.01). Using ultrasound scan, the prevalence of the bladder lesions reached its previous level in both villages. However the prevalence of hydronephrosis decreased from 21.1% to 3.9% in K. éno (p < 0.001) and from 12.6% to 4.2% in Téguey (p < 0.001). Three years after the single mass treatment, the morbidity did not reach the initial level. The effectiveness of the treatment is better in the pond system where the transmission is seasonal. The lesions of the upper tract decreased more slowly than the bladder lesions, but a long time after the treatment. The re-infestation induced the re-appearance of the bladder lesions sooner than the lesions of the upper tract. The periodicity of the treatment should be variable according to the transmission system. It should occur every 2 years in irrigated areas and could be delayed (3 years) in temporary ponds. The control was beneficial in the pond system and induced a significant reduction of the severe lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104149

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  14 in total

Review 1.  Schistosomiasis--an unusual cause of ureteral obstruction: a case history and perspective.

Authors:  Peter M Neal
Journal:  Clin Med Res       Date:  2004-11

2.  The WHO ultrasonography protocol for assessing morbidity due to Schistosoma haematobium. Acceptance and evolution over 14 years. Systematic review.

Authors:  Robert Akpata; Andreas Neumayr; Martha C Holtfreter; Ingela Krantz; Daman D Singh; Rodrigo Mota; Susanne Walter; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2015-02-25       Impact factor: 2.289

3.  Case-Control Study of Posttreatment Regression of Urinary Tract Morbidity Among Adults in Schistosoma haematobium-Endemic Communities in Kwale County, Kenya.

Authors:  Philip Magak; Alicia Chang-Cojulun; Hilda Kadzo; Edmund Ireri; Eric Muchiri; Uriel Kitron; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2015-05-26       Impact factor: 2.345

4.  Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.

Authors:  Seydou Touré; Yaobi Zhang; Elisa Bosqué-Oliva; Césaire Ky; Amado Ouedraogo; Artemis Koukounari; Albis F Gabrielli; Sellin Bertrand; Joanne P Webster; Alan Fenwick
Journal:  Bull World Health Organ       Date:  2008-10       Impact factor: 9.408

5.  Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel.

Authors:  Abedaziz M Ahmed; Hana Abbas; Fathi A Mansour; Gasim I Gasim; Ishag Adam
Journal:  Parasit Vectors       Date:  2012-06-07       Impact factor: 3.876

6.  Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period.

Authors:  Bruno Senghor; Omar Talla Diaw; Souleymane Doucoure; Seydou Nourou Sylla; Mouhamadane Seye; Idrissa Talla; Cheikh Tidiane Bâ; Adiouma Diallo; Cheikh Sokhna
Journal:  Parasit Vectors       Date:  2015-07-10       Impact factor: 3.876

7.  Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal.

Authors:  Bruno Senghor; Omar Talla Diaw; Souleymane Doucoure; Mouhamadane Seye; Adiouma Diallo; Idrissa Talla; Cheikh T Bâ; Cheikh Sokhna
Journal:  PLoS Negl Trop Dis       Date:  2016-03-25

Review 8.  Drugs for treating urinary schistosomiasis.

Authors:  Christine V Kramer; Fan Zhang; David Sinclair; Piero L Olliaro
Journal:  Cochrane Database Syst Rev       Date:  2014-08-06

9.  Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment.

Authors:  Aly Landouré; Robert Dembélé; Seydou Goita; Mamadou Kané; Marjon Tuinsma; Moussa Sacko; Emily Toubali; Michael D French; Adama D Keita; Alan Fenwick; Mamadou S Traoré; Yaobi Zhang
Journal:  PLoS Negl Trop Dis       Date:  2012-07-31

10.  Controlling schistosomiasis: significant decrease of anaemia prevalence one year after a single dose of praziquantel in Nigerian schoolchildren.

Authors:  Zilahatou B Tohon; Halima B Mainassara; Amadou Garba; Ali E Mahamane; Elisa Bosqué-Oliva; Maman-Laminou Ibrahim; Jean-Bernard Duchemin; Suzanne Chanteau; Pascal Boisier
Journal:  PLoS Negl Trop Dis       Date:  2008-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.